BBLG - Bone Biologics Corp

https://www.bonebiologics.com

Momentum: Bearish

Recent News

Why Is Bone Biologics Stock Surging On Friday? - Bone Biologics ( NASDAQ:BBLG )

Benzinga • 2 months, 2 weeks ago • score: 0.29

Bone Biologics' trading volume surged to 17.22M, far above its 38.8K average. The company expects $5 million from the offering, with up to $10 million more if warrants are exercised. Market-moving news hits Benzinga Pro first-get a 30-minute edge and save 60% this 4th of July.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using recombinant human protein. The company is headquartered in Burlington, Massachusetts.

52W High

$16.50

52W Low

$2.03

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.30

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

0.14

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

0.63

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

8.31%

Institutions (25–75% balanced)

0.12%

Shares Outstanding

1,795,300

Float

1,639,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-21.39

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.89%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

-0.1557

-0.1618

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025